ALAna Cláudia Frota Machado de Melo Lopes

Ana Cláudia Frota Machado de Melo Lopes

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Ana Cláudia Frota Machado de Melo Lopes has a total of 25 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    The influence of Epstein-Barr virus in the microenvironment of classic Hodgkin lymphoma: A focus on T-cells and macrophages

    by Ana Claudia Frota Melo, Valéria Buccheri, Jackson A. Barbosa, R.S. Azevedo, Mario L. Marques-Piubelli, Mcn. Zerbini

  • Open Access

    HER2 discordance between primary and metastatic gastric cancer: a systematic review and meta-analysis

    by Francisco Cezar Aquino Moraes, Luis Henrique Rios Moreira Rego, Thiago Gorayeb Rebelo, Gustavo Tadeu Freitas Uchôa Matheus, Ana C. Melo

    Purpose: Gastric cancer (GC) remains a major global health burden, with poor survival rates. HER2 is a key biomarker for targeted therapy, but discordance between primary tumors and metastases may impact treatment decisions. This meta-analysis evaluated the prevalence and clinical relevance of HER2 status differences between primary gastric cancers and metastatic lesions. Methods: A systematic search of PubMed, Embase, and Cochrane was conducted for studies assessing HER2 status in matched primary and metastatic gastric cancer samples. Pooled proportions and 95% confidence intervals (CIs) were calculated using random-effects models. Subgroup analyses by metastatic site were performed. Statistical analyses were conducted using R software, version 4.2.3. Results: This meta-analysis included 3,515 patients across 20 studies. The pooled proportion of HER2-positive expression in primary gastric tumors was 13% (95% CI: 12–15%; I 2 = 68.7%), while HER2-negative tumors accounted for 74% (95% CI: 72%-76%; I 2 = 94.9%). In metastatic sites, the overall pooled proportion of HER2-positive lesions was 18% (95% CI: 16%-20%; I 2 = 77.3%), with notable variation across anatomical locations: 38% in lung metastases, 31% in liver metastases, 19% in lymph nodes, and 7% in peritoneum. Conversely, HER2-negative metastases accounted for 82% overall (95% CI: 80%-84%; I 2 = 78.2%), with proportions of 93% in peritoneum, 81% lymph nodes, 69% in liver metastases, and 62% in lung. Conclusions: Significant heterogeneity in HER2 expression between primary and metastatic gastric cancer underscores the need for reassessment of HER2 status in metastatic sites. Relying solely on primary tumor samples may lead to underestimation of HER2 positivity and suboptimal therapeutic decisions. Incorporating site-specific HER2 testing into clinical practice may enhance patient selection for HER2-targeted therapies and improve treatment outcomes. Graphic


  • Open Access

    Parâmetros bioquímicos e morfológicos em ratos diabéticos tratados com extratos de Ora-Pro-Nóbis (Pereskia aculeata)

    by João Paulo Lopes Jordão, Gabriel Lopes Chaves, Guilherme Fantinato, Kamila Oliveira de Luca Rotondo, Michele Caroline Terra, Sofia de Castro Oliveira, Aluisio Eustáquio de Freitas Miranda Filho, Ana Claudia Frota Lopes, Roberta Bessa Veloso Silva, Bruno Cesar Correa Salles, et al.

    Diabetes mellitus (DM) is a serious global public health problem. DM complications corroborate with high morbidity and mortality rates. Thus, several plant species have been studied regarding their medicinal properties with potential use in the treatment of DM and/or its complications. This study evaluated the effects of leaf (LE-OPN) and bark (BE-OPN) extracts from ora-pro-nóbis (Pereskia aculeata) on biochemical parameters (glycemia, triglycerides, total cholesterol, creatine, urea, AST and ALT, and lipid peroxidation) and histology (heart, liver and kidneys) in animals with DM. Induction of type 1 DM (glycemia > 200 mg/dl) in male Wistar rats was performed with Alloxane (150 mg/kg/ml). The animals were divided into 4 groups: (1) without DM, (2) with DM, (3) with DM treated with LE-OPN and (4) with DM treated with BE-OPN. The treatment was done by gavage (300 mg/kg/day) for 4 weeks. After this period the parameters were evaluated. BE-OPN prevented the increase in triglycerides, AST, ALT, and urea, in addition to lipid peroxidation (p < 0.05). The results suggest a potential for BE-OPN to prevent typical complications of DM, improving the lipid profile, liver, and kidney, as well as attenuating oxidative stress.

  • Open Access

    EFEITO DOS EXTRATOS DAS FOLHAS DE GUINÉ (PETIVERIA ALLIACEA L) SOBRE PARÂMETROS BIOQUÍMICOS E HISTOLÓGICOS EM RATOS DIABÉTICOS

    by Jéssica De Cássia Santos, Leticia Mendonça Botelho, Isabela Morais Bento, Rafaela Gontijo Lima, Sofia De Castro Oliveira, Layla Pereira de Carvalho, Roberta Bessa Veloso, Ana Cláudia Frota Machado de Melo Lopes, Bruno Cesar Correia Salles, Gersika Bitencourt Santos Barros

    O Diabetes Mellitus (DM) é um distúrbio endócrino e metabólico cada vez mais comum na população mundial, carente de novas alternativas terapêuticas, sendo os vegetais uma alternativa viável na busca por novos fitoterápicos e bioativos com ação para controlar o DM. Devido a atividade hipoglicemiante de alguns bioativos das folhas de Guiné (Petiveria alliacea), além de esta ser uma planta amplamente difundida pelo Brasil, de fácil cultivo e acesso, o presente estudo avaliou a influência dos extratos das folhas de Guiné sobre parâmetros bioquímicos e morfológicos de ratos Wistar com DM induzido por aloxano. Os animais foram divididos em três grupos experimentais: ratos sem DM (n = 10), ratos com DM (n = 10) e ratos com DM tratados com o extrato das folhas de P. alliacea (200mg/Kg/dia) (n = 10). Os parâmetros bioquímicos: glicose, perfil hepático (TGP e TGO), renal (creatinina e ureia) e lipídico (colesterol total e triglicerídeos), bem como a histologia de órgãos foram avaliadas. O extrato da folha de P. alliacea, na dose de 200mg/Kg/dia, não foi capaz de prevenir os aumentos dos níveis de glicose, TGP, TGO, creatinina, ureia, colesterol total e triglicerídeos, em animais com DM comparados ao grupo DM não tratado. Não houve alterações histopatológicas significativas no fígado, rins, coração, e glândulas salivares. Ressalta-se a necessidade de novos estudos para avaliar tais achados preliminares, visando esclarecer os efeitos aqui observados.